Bandaram Pharma

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE875N01036
  • NSEID:
  • BSEID: 524602
INR
20.79
0.64 (3.18%)
BSENSE

Sep 25, 09:17 AM

BSE+NSE Vol: 16

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
EQUITY AND LIABILITIES
No of Months
12
12
12
12
Share Capital
17.97
12.00
12.00
3.00
Share Warrants & Outstandings
Total Reserve
8.81
0.65
0.28
0.08
Shareholder's Funds
26.78
12.65
12.28
3.08
Minority Interest
4.58
3.17
2.79
2.05
Long-Term Borrowings
10.05
8.99
4.68
7.65
Secured Loans
1.15
2.36
1.78
1.97
Unsecured Loans
8.90
6.63
2.89
5.68
Deferred Tax Assets / Liabilities
0.12
0.07
0.08
0.05
Other Long Term Liabilities
0
0
0
0
Long Term Trade Payables
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
10.17
9.06
4.76
7.69
Current Liabilities
Trade Payables
16.26
4.36
4.12
0.24
Other Current Liabilities
3.64
1.18
0.37
0.37
Short Term Borrowings
13.89
8.16
7.53
6.56
Short Term Provisions
0.53
0.33
0.22
0.19
Total Current Liabilities
34.33
14.03
12.24
7.35
Total Liabilities
75.86
38.92
32.06
20.17
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
Gross Block
15.22
3.95
5.91
5.03
Less: Accumulated Depreciation
0.00
0.00
1.43
0.00
Less : Impairment of Assets
0.00
0.00
0.00
0.00
Net Block
15.22
3.95
4.48
5.03
Lease Adjustment
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
Non Current Investments
0.00
1.40
1.40
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
Other Non Current Assets
3.65
2.69
0.11
0.08
Total Non-Current Assets
18.87
8.04
5.99
5.11
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
Inventories
12.94
8.51
6.47
2.71
Sundry Debtors
31.35
18.76
14.52
6.62
Cash and Bank
0.72
0.12
0.04
0.16
Other Current Assets
2.57
2.30
2.69
2.01
Short Term Loans and Advances
9.41
1.20
2.34
3.56
Total Current Assets
56.99
30.88
26.06
15.06
Net Current Assets (Including Current Investments)
22.67
16.85
13.83
7.71
Total Current Assets Excluding Current Investments
56.99
30.88
26.06
15.06
Miscellaneous Expenses not written off
3.49
2.69
0.01
0.02
Total Assets
75.86
38.92
32.06
20.17
Contingent Liabilities
0.00
0.00
0.00
0.00
Total Debt
23.95
17.15
12.20
14.20
Book Value per share (adjusted)
14.9
10.54
10.23
3.57651053644179
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 39.65% vs 40.57% in Mar 2025

stock-summary

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 285.32% vs -11.83% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is -100.00% vs 0.00% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 84.55% vs 18.50% in Mar 2025

Compare Balance Sheet Results of Bandaram Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
17.97
0
17.97
0.00%
Share Warrants & Outstandings
Total Reserve
8.81
0
8.81
0.00%
Shareholder's Funds
26.78
0
26.78
0.00%
Minority Interest
4.58
0
4.58
0.00%
Long-Term Borrowings
10.05
0
10.05
0.00%
Secured Loans
1.15
0
1.15
0.00%
Unsecured Loans
8.90
0
8.90
0.00%
Deferred Tax Assets / Liabilities
0.12
0
0.12
0.00%
Other Long Term Liabilities
0.00
0
0.00
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
0.00
0
0.00
0.00%
Total Non-Current Liabilities
10.17
0
10.17
0.00%
Current Liabilities
Trade Payables
16.26
0
16.26
0.00%
Other Current Liabilities
3.64
0
3.64
0.00%
Short Term Borrowings
13.89
0
13.89
0.00%
Short Term Provisions
0.53
0
0.53
0.00%
Total Current Liabilities
34.33
0
34.33
0.00%
Total Liabilities
75.86
0
75.86
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
15.22
0
15.22
0.00%
Less: Accumulated Depreciation
0.00
0
0.00
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
15.22
0
15.22
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
0.00
0
0.00
0.00%
Intangible assets under development
0.00
0
0.00
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
0.00
0
0.00
0.00%
Long Term Loans & Advances
0.00
0
0.00
0.00%
Other Non Current Assets
3.65
0
3.65
0.00%
Total Non-Current Assets
18.87
0
18.87
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0
0.00
0.00%
Inventories
12.94
0
12.94
0.00%
Sundry Debtors
31.35
0
31.35
0.00%
Cash and Bank
0.72
0
0.72
0.00%
Other Current Assets
2.57
0
2.57
0.00%
Short Term Loans and Advances
9.41
0
9.41
0.00%
Total Current Assets
56.99
0
56.99
0.00%
Net Current Assets (Including Current Investments)
22.67
0
22.67
0.00%
Total Current Assets Excluding Current Investments
56.99
0
56.99
0.00%
Miscellaneous Expenses not written off
3.49
0
3.49
0.00%
Total Assets
75.86
0
75.86
0.00%
Contingent Liabilities
0.00
0
0.00
0.00%
Total Debt
23.95
0
23.95
0.00%
Book Value per share (adjusted)
14.90
0
14.90
0.00%
Annual - Borrowings
Borrowings 23.95 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 39.65% vs 40.57% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2026

Figures in Cr
stock-summary

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets
Fixed Assets 15.22 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 285.32% vs -11.83% in Mar 2025

Annual - Investments
Investments 0.00 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -100.00% vs 0.00% in Mar 2025

Annual - Current Assets
Current Assets 56.99 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 84.55% vs 18.50% in Mar 2025

Footer loading